Pressmeddelande

BioStock: Sprint Bioscience invests to expand portfolio and number of deals

Cision Publicerad: 16 Dec 2021 08:36

Huddinge-based Sprint Bioscience has had an eventful 2021 to say the least. In the face of the success of the past year, the company is now taking concrete steps to be able to increase the pace even further. The goal for the company is to broaden its portfolio of preclinical drug programmes in cancer and increase the number of programmes licensed to partners, thus increasing the potential for multiple revenue streams.

Read the full article at biostock.se:

https://www.biostock.se/en/2021/12/sprint-bioscience-invests-to-expand-portfolio-and-number-of-deals/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Sprint Bioscience

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!